- Filed
- Oct 11, 2023 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · Feb 13, 2023 | 299.69M sh |
| Shares Diluted | Q1 2023 · Dec 31, 2022 | 299.69M sh |
| Shares Diluted | Q1 2023 · Dec 31, 2021 | 299.69M sh |
| Capex | Q1 2023 · Dec 31, 2022 | $15.01K |
| Operating Cash Flow | Q1 2023 · Dec 31, 2022 | −$74.87K |
| Operating Cash Flow | Q1 2023 · Dec 31, 2021 | −$71.54K |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $46.53K |
| Cash And Equivalents | Q1 2023 · Sep 30, 2022 | $136.4K |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | −$214.47K |
| Stockholders Equity | Q1 2023 · Sep 30, 2022 | −$83.35K |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | $149.38K |
| Stockholders Equity | Q1 2023 · Sep 30, 2021 | $253.47K |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $252.68K |
| Current Liabilities | Q1 2023 · Sep 30, 2022 | $205.02K |
| Current Assets | Q1 2023 · Dec 31, 2022 | $53.18K |
| Current Assets | Q1 2023 · Sep 30, 2022 | $150.89K |
| Total Assets | Q1 2023 · Dec 31, 2022 | $68.19K |
| Total Assets | Q1 2023 · Sep 30, 2022 | $150.89K |
| Sga Expense restated | Q1 2023 · Dec 31, 2022 | $149K |
| Sga Expense | Q1 2023 · Dec 31, 2021 | $103.34K |
| Net Income restated | Q1 2023 · Dec 31, 2022 | −$149.79K |
| Net Income | Q1 2023 · Dec 31, 2021 | −$104.09K |
| Operating Income restated | Q1 2023 · Dec 31, 2022 | −$149K |
| Operating Income | Q1 2023 · Dec 31, 2021 | −$103.34K |